Results 191 to 200 of about 48,780 (298)

When cues take the wheel: cue-control across alcohol use disorder, binge-eating disorder, gambling disorder, and internet gaming disorder. [PDF]

Front Psychol
Bode EL, Krasniqi S, Rosenthal A, Friedel E, Schlagenhauf F, Sebold M.   +5 more
europepmc   +1 more source

An examination of core beliefs in generalized anxiety disorder

British Journal of Clinical Psychology, EarlyView.
Abstract Objective Generalised anxiety disorder (GAD) is characterised by uncontrollable worries. Cognitive behaviour therapy (CBT) is an effective treatment for GAD; however, manualised treatments rarely include interventions to target core beliefs. This study aimed to (1) explore the core beliefs about the self that are endorsed by individuals with ...
Amy E. Doust, Vesna Trenoska Basile, Sarah McDonald, Toby Newton‐John, Bethany M. Wootton   +4 more
wiley   +1 more source

"Binge eating disorder is the slum of eating disorders": a qualitative study of Norwegian women with binge eating disorder in the encounter with the healthcare system. [PDF]

J Eat Disord
Riise J, Gulliksen KS, Vrabel K, Halvorsen MS.   +3 more
europepmc   +1 more source

Incidental Resolution of Dopamine Agonist Induced Impulse Control Disorder with GLP‐1 Receptor Agonist

Movement Disorders Clinical Practice, EarlyView.
Hannah Kelly, Thomas Davis
wiley   +1 more source

Cognitive behavioural therapy compared to control conditions in treating bulimia nervosa and binge‐eating disorder: A systematic review and meta‐analysis

British Journal of Clinical Psychology, EarlyView.
Abstract Objective Our systematic review and meta‐analysis aimed to investigate how Cognitive‐Behavioural Therapy (CBT) performs against control conditions, such as waiting‐list, self‐help interventions, psychological and pill placebos and treatment as usual (TAU) in Bulimia Nervosa (BN) and Binge Eating Disorder (BED).
Angeliki L. Sioziou, Anastasios Stefanou, Felicia Dimitrakopoulou, Menelaos Skarlatos, Andreas S. Lappas, Christina Mesiari, Aikaterini Argyrou, Evangelos Ntouros, Nikolaos Christodoulou, Vasilios‐Panteleimon Bozikas, Myrto Samara   +10 more
wiley   +1 more source

To vary or not to vary: A flexible empirical Bayes factor for testing variance components

British Journal of Mathematical and Statistical Psychology, EarlyView.
Abstract Random effects are the gold standard for capturing structural heterogeneity, such as individual differences or temporal dependence. Yet testing their presence is difficult because variance components are constrained to be non‐negative, creating a boundary problem. This paper introduces a flexible empirical Bayes factor (EBF) for testing random
Fabio Vieira, Hongwei Zhao, Joris Mulder
wiley   +1 more source

Attentional bias toward food in binge eating disorder: baseline differences and the limits of attention modification training. [PDF]

J Eat Disord
Sablottny L, Werle D, Svaldi J, Thörel N, Caffier D, Tuschen-Caffier B.   +5 more
europepmc   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Visible yet Invisible: embodied meanings of weight stigma among women with binge eating disorder and higher weight. [PDF]

Int J Qual Stud Health Well-being
Berg KH, Natvik E, Jahren L, Eik-Nes TT.
europepmc   +1 more source

Inhibition of peripheral CB1 receptors modulates food intake and metabolic efficiency in obesity independently of the gut–brain vagal axis

British Journal of Pharmacology, EarlyView.
Background and Purpose Obesity involves profound disruptions in neuronal circuits, neuroendocrine communication and the endocannabinoid system. While global blockade of cannabinoid CB1 receptors improves metabolism, its clinical use is limited by neuropsychiatric side effects.
Oriane Onimus, Camille de Almeida, Benoit Bertrand, Julien Castel, Nejmeh Mashhour, Anthony Ansoult, Serge Luquet, Giuseppe Gangarossa   +7 more
wiley   +1 more source